Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Mechanism of Action in CBT (MAC): Methods of a multi-center randomized controlled trial in 369 patients with Panic Disorder and Agoraphobia
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1722530
Author(s) Gloster, A. T.; Wittchen, H. -U.; Einsle, F.; Höfler, M.; Lang, T.; Fydrich, T.; Fehm, L.; Hamm, A. O.; Richter, J.; Alpers, G. W.; Gerlach, A. L. .; Ströhle, A.; Kircher, T.; Deckert, J.; Zwanzger, P.; Arolt, V.
Author(s) at UniBasel Gloster, Andrew
Year 2009
Title Mechanism of Action in CBT (MAC): Methods of a multi-center randomized controlled trial in 369 patients with Panic Disorder and Agoraphobia
Journal European Archives of Psychiatry and Clinical Neuroscience
Volume 259 Suppl 2
Number S2
Pages / Article-Number S155-66
Abstract Cognitive behavioral therapy (CBT) is efficacious for panic disorder with agoraphobia (PD/A). Nevertheless, the active ingredients of treatment and the mechanisms through which CBT achieves its effects remain largely unknown. The mechanisms of action in CBT (MAC) study was established to investigate these questions in 369 patients diagnosed with PD/A. The MAC study utilized a multi-center, randomized controlled design, with two active treatment conditions in which the administration of exposure was varied, and a wait-list control group. The special feature of MAC is the way in which imbedded experimental, psychophysiological, and neurobiological paradigms were included to elucidate therapeutic and psychopathological processes. This paper describes the aims and goals of the MAC study and the methods utilized to achieve them. All aspects of the research design (e.g., assessments, treatment, experimental procedures) were implemented so as to facilitate the detection of active therapeutic components, and the mediators and moderators of therapeutic change. To this end, clinical, behavioral, physiological, experimental, and genetic data were collected and will be integrated.
Publisher Springer
ISSN/ISBN 0940-1334 ; 1433-8491
edoc-URL http://edoc.unibas.ch/48945/
Full Text on edoc No
Digital Object Identifier DOI 10.1007/s00406-009-0065-6
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/19876674
Document type (ISI) Journal Article, Multicenter Study, Randomized Controlled Trial
 
   

MCSS v5.8 PRO. 0.362 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
02/05/2024